BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32641297)

  • 1. Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.
    Aroua N; Boet E; Ghisi M; Nicolau-Travers ML; Saland E; Gwilliam R; de Toni F; Hosseini M; Mouchel PL; Farge T; Bosc C; Stuani L; Sabatier M; Mazed F; Larrue C; Jarrou L; Gandarillas S; Bardotti M; Picard M; Syrykh C; Laurent C; Gotanègre M; Bonnefoy N; Bellvert F; Portais JC; Nicot N; Azuaje F; Kaoma T; Joffre C; Tamburini J; Récher C; Vergez F; Sarry JE
    Cancer Discov; 2020 Oct; 10(10):1544-1565. PubMed ID: 32641297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.
    Farge T; Saland E; de Toni F; Aroua N; Hosseini M; Perry R; Bosc C; Sugita M; Stuani L; Fraisse M; Scotland S; Larrue C; Boutzen H; Féliu V; Nicolau-Travers ML; Cassant-Sourdy S; Broin N; David M; Serhan N; Sarry A; Tavitian S; Kaoma T; Vallar L; Iacovoni J; Linares LK; Montersino C; Castellano R; Griessinger E; Collette Y; Duchamp O; Barreira Y; Hirsch P; Palama T; Gales L; Delhommeau F; Garmy-Susini BH; Portais JC; Vergez F; Selak M; Danet-Desnoyers G; Carroll M; Récher C; Sarry JE
    Cancer Discov; 2017 Jul; 7(7):716-735. PubMed ID: 28416471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
    Hosseini M; Rezvani HR; Aroua N; Bosc C; Farge T; Saland E; Guyonnet-Dupérat V; Zaghdoudi S; Jarrou L; Larrue C; Sabatier M; Mouchel PL; Gotanègre M; Piechaczyk M; Bossis G; Récher C; Sarry JE
    Cancer Res; 2019 Oct; 79(20):5191-5203. PubMed ID: 31358527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
    Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
    Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Mitochondrial Mechanisms of Cytarabine Resistance in Primary AML Cells.
    Schimmer AD
    Cancer Discov; 2017 Jul; 7(7):670-672. PubMed ID: 28684410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
    Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
    Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy.
    Cartel M; Mouchel PL; Gotanègre M; David L; Bertoli S; Mansat-De Mas V; Besson A; Sarry JE; Manenti S; Didier C
    Leukemia; 2021 Feb; 35(2):417-432. PubMed ID: 32447346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
    Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
    Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 Facilitates Acute Myeloid Leukemia Chemoresistance via Mitofusin 1-Mediated Mitochondrial Fusion.
    Hou D; Zheng X; Cai D; You R; Liu J; Wang X; Liao X; Tan M; Lin L; Wang J; Zhang S; Huang H
    Mol Cancer Res; 2023 Dec; 21(12):1366-1378. PubMed ID: 37698549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage.
    Xie C; Edwards H; Caldwell JT; Wang G; Taub JW; Ge Y
    Mol Oncol; 2015 Feb; 9(2):409-21. PubMed ID: 25308513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
    Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.
    Malani D; Murumägi A; Yadav B; Kontro M; Eldfors S; Kumar A; Karjalainen R; Majumder MM; Ojamies P; Pemovska T; Wennerberg K; Heckman C; Porkka K; Wolf M; Aittokallio T; Kallioniemi O
    Leukemia; 2017 May; 31(5):1187-1195. PubMed ID: 27833094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine.
    Visser N; Lourens HJ; Huls G; Bremer E; Wiersma VR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells.
    Luna-Yolba R; Marmoiton J; Gigo V; Marechal X; Boet E; Sahal A; Alet N; Abramovich I; Gottlieb E; Visentin V; Paillasse MR; Sarry JE
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
    Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S
    Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
    Levin M; Stark M; Berman B; Assaraf YG
    Cell Death Dis; 2019 May; 10(6):390. PubMed ID: 31101804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.
    Picou F; Debeissat C; Bourgeais J; Gallay N; Ferrié E; Foucault A; Ravalet N; Maciejewski A; Vallet N; Ducrocq E; Haddaoui L; Domenech J; Hérault O; Gyan E
    Pharmacol Res; 2018 Oct; 136():45-55. PubMed ID: 30142422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.